Effectiveness and safety of drugs used for stroke prevention in a cohort of non-valvular atrial fibrillation patients from a primary care electronic database (vol 26, pg 97, 2017)

Giner-Soriano M.; Roso-Llorach A.; Urgell Vedia C.; Castells X.; Capella D.; Ferreira-Gonzalez I; Elorza-Ricart J. M.; Casajuana M.; Marino Troncoso A.; Diogene E.; Bolibar B.; Violan C.; Morros R.

首页> 外文期刊>Pharmacoepidemiology and drug safety >Effectiveness and safety of drugs used for stroke prevention in a cohort of non-valvular atrial fibrillation patients from a primary care electronic database (vol 26, pg 97, 2017)

【24h】

Effectiveness and safety of drugs used for stroke prevention in a cohort of non-valvular atrial fibrillation patients from a primary care electronic database (vol 26, pg 97, 2017)

机译：用于初级保健电子数据库的非瓣膜心房颤动患者队列中风预防药物的有效性和安全性（Vol 26，PG 97,2017）

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

团队文献服务 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Pharmacoepidemiology and drug safety 》 |2017年第8期| 共1页
作者
Giner-Soriano M.; Roso-Llorach A.; Urgell Vedia C.; Castells X.; Capella D.; Ferreira-Gonzalez I; Elorza-Ricart J. M.; Casajuana M.; Marino Troncoso A.; Diogene E.; Bolibar B.; Violan C.; Morros R.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类药学 ;
关键词

相似文献

外文文献
中文文献
专利

1. Effectiveness and safety of drugs used for stroke prevention in a cohort of non-valvular atrial fibrillation patients from a primary care electronic database (vol 26, pg 97, 2017) [J] . Giner-Soriano M., Roso-Llorach A., Urgell Vedia C., Pharmacoepidemiology and drug safety . 2017 ,第8期

机译：用于初级保健电子数据库的非瓣膜心房颤动患者队列中风预防药物的有效性和安全性（Vol 26，PG 97,2017）
2. Effectiveness, safety and costs of thromboembolic prevention in patients with non-valvular atrial fibrillation: phase I ESC-FA protocol study and baseline characteristics of a cohort from a primary care electronic database [J] . Albert Roso-Llorach, Amelia Troncoso Mari?o, Bonaventura Bolíbar, BMJ Open . 2016 ,第1期

机译：非瓣膜性心房颤动患者血栓栓塞预防的有效性，安全性和费用：ESC-FA方案I期研究和基层医疗电子数据库的队列基线特征
3. Study Design and Baseline Characteristics of the EXPAND Study: Evaluation of Effectiveness and Safety of Xa Inhibitor, Rivaroxaban for the Prevention of Stroke and Systemic Embolism in a Nationwide Cohort of Japanese Patients Diagnosed as Non-Valvular Atrial Fibrillation [J] . Ikeda Takanori, Atarashi Hirotsugu, Inoue Hiroshi, The Tohoku Journal of Experimental Medicine . 2016 ,第4期

机译：EXPAND研究的研究设计和基线特征：评价在全国范围内被诊断为非瓣膜性心房颤动的日本患者中，Xa抑制剂，利伐沙班预防中风和系统性栓塞的有效性和安全性
4. Comparative and Cost-effectiveness of Stroke Prevention Treatments in Atrial Fibrillation: A New Generation of Drugs. [D] . Tawfik, Amy. 2015

机译：心房颤动中风预防治疗的比较和成本效益：新一代药物。
5. Effectiveness safety and costs of thromboembolic prevention in patients with non-valvular atrial fibrillation: phase I ESC-FA protocol study and baseline characteristics of a cohort from a primary care electronic database [O] . Maria Giner-Soriano, Cristina Vedia Urgell, Albert Roso-Llorach, 2016

机译：非瓣膜性心房颤动患者血栓栓塞预防的有效性安全性和费用：ESC-FA I方案I期研究和基层医疗电子数据库中人群的基线特征
6. Effectiveness and safety of thromboembolic prevention in patients with non-valvular atrial fibrillation: ESC-FA study. A cohort from a Primary Healthcare electronic database [O] . Giner Soriano Maria 2016

机译：非瓣膜性房颤患者血栓栓塞预防的有效性和安全性：ESC-FA研究。来自初级医疗保健电子数据库的队列

Effectiveness and safety of drugs used for stroke prevention in a cohort of non-valvular atrial fibrillation patients from a primary care electronic database (vol 26, pg 97, 2017)

著录项

相似文献

相关主题

期刊订阅